Urinary Retention: Clinical Trials

2 trials for Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 11Recruiting 1

Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial
Tamsulosin Hydrochloride, Placebo - Urinary Retention Postoperative
Phase 2RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's602024-10-012024-10-28
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
Tamsulosin - 1 week, Tamsulosin - 3 days - Urinary Retention
Phase 1 / Phase 2RecruitingHackensack Meridian Health1272018-05-072026-06-11

Narrower conditions

Lung Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Lung Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Tamsulosin (2)

Sponsors

Hackensack Meridian Health (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Michael Spallone, MD (1)  ·  Rahul Nayal (1)